SEARCH

SEARCH BY CITATION

REFERENCES

  • References to studies included in this review
  • Arif 2005 {published data only}
  • Arif B, Ferhan K. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study. Pediatrics International 2005;47:67-71.
  • Avent 2002 {published data only}
  • Avent M, Cory BJ, Galpin J, Ballot DE, Cooper PA, Sherman G, Davies VA. A comparison of high versus low dose recombinant human erythropoietin versus blood transfusion in the managemant of anaemia of prematurity in a developing country. Journal of Tropical Pediatrics 2002;48:227-33.
  • Bierer 2006 {published data only}
  • Bierer R, Peceny C, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopment outcome in preterm infants. Pediatrics 2006;118:e635-40.
  • Carnielli 1992 {published data only}
  • Carnielli V, Montini G, Da Riol R, Dall'Amico R, Cantarutti F. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants. Journal of Pediatrics 1992;121:98-102.
  • Carnielli 1998 {published data only}
  • Carnielli VP, Riol RD, Montini G. Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Archieves of Disease in Childhood Fetal Neonatal Edition 1998;79:F44-8.
  • Chang 1998 {published data only}
  • Chang L, Liu W, Liao C, Zhao X. Preventive effects of different dosages of recombinant human erythropoietin on anemia of premature infants. Journal of Tongji Medical University 1998;18:239-42.
  • Fauchère 2008 {published data only}
  • Fauchère J-C, Dame C, Vonthein R, Koller B, Arri S, Wolf M, Bucher HU. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 2008;122:375-82.
  • Haiden 2005 {published data only}
  • * Haiden N, Cardona F, Schwindt J, Berger A, Kuhle S, Homoncik M, et al.Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thrombosis and Haemostasis 2005;93:118-23.
  • He 2008 {published data only}
  • He JS, Huang ZL, Yang H, Weng KZ, Zhu SB. Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 2008;10:586-8.
  • Khatami 2008 {published data only}
  • Khatami SF, Mamouri G, Torkaman M. Effects of early human recombinant erythropoietin therapy on the transfusion in healthy preterm infants. Indian Journal of Pediatrics 2008;75:1227-30.
  • Lauterbach 1995 {published data only}
  • Lauterbach R, Kachlik P, Pawlik D, Bajorek I. Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin. Pediatria Polska 1995;70:739-44.
  • Lima-Rogel 1998 {published data only}
  • Lima-Roogel V, Torres-Montes A, Griesse SE, Alvarez CV, Hernandez-Sierra F, Mandeville PB, et al.Efficacy of early erythropoietin use in critically ill very-low-birth-weight premature newborn infants: controlled clinical trial [Eficacia del uso precoz de eritropoyetina en recien nacidos pretermino de muy bajo peso, criticamente enfermos: ensayo clinico controlado]. Sangre 1998;43:191-5.
  • Maier 1994 {published data only}
  • Maier RF, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al.The effect of epoetin beta (recombinant human eryhtropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. New England Journal of Medicine 1994;330:1173-8.
  • Maier 2002 {published and unpublished data}
  • Maier RF, Obladen M, Muller-Hansen I, Kattner E, Merz U, Arlettaz R, et al.Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. Journal of Pediatrics 2002;141:8-15.
  • Meister 1997 {published data only}
  • Meister B, Maurer H, Simma B, Kern H, Ulmer H, Hittmair A. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants. Stem Cells 1997;15:359-63.
  • Meyer 2003 {published data only}
  • Meyer MP, Sharma E, Carsons M. Recombinant erythropoietin and blood transfusion in selected infants. Archieves of Disease in Childhood Fetal Neonatal Edition 2003;88:F41-5.
  • Obladen 1991 {published data only}
  • Obladen M, Maier R, Segerer H, Grauel EL, Holland BM, Stewart G, et al.Efficacy and safety of recombinant human erythropoietin to prevent the anemias of prematurity. European Randomized Multicenter Trial. Contributions to Nephrology 1991;88:314-26.
  • Ohls 1995 {published data only}
  • Ohls RK, Osborne KA, Christensen RD. Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. Journal of Pediatrics 1995;126:421-6.
  • Ohls 1997 {published data only}
  • Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double blind, placebo-controlled study. Journal of Pediatrics 1997;131:661-5.
  • Ohls 2001A {published data only}
  • Ehrenkranz RA, Ohls RK, Das A, Vohr BR. Neurodevelopmental outcome and growth at 18-22 months in extremely low birth weight infants treated with early eryhtropoietin. Pediatric Research 2002;51:291A.
  • Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, et al.Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics 2004;114:1287-91.
  • Ohls RK, Ehrenkranz RA, Lemons JA, Korones SB, Stoll BJ, Stark AR, et al.A multicenter randomized double-masked placebo-controlled trial of early erythropoietin and iron administration to preterm infants. Pediatric Research 1999;45:216 A.
  • * Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al.Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001;108:934-42.
  • Ohls 2001B {published data only}
  • Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ, et al.Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 2001;108:934-42.
  • Romagnoli 2000 {published data only}
  • Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?. European Journal of Pediatrics 2000;159:627-8.
  • Salvado 2000 {published data only}
  • Salvado A, Ramolfo P, Escobar M, Nunez A, Aguayo I, Standen J, et al.Early erythropoietin use for the prevention of anemia in infant premature [Uso precoz de la eritropoyetina en la prevencion de la anemia del prematuro]. Revista Medica de Chile 2000;128:1313-7.
  • Soubasi 1993 {published data only}
  • Soubasi V, Kremenopoulos G, Diamandi E, Tsantali C, Tsakiris D. In which neonates does early recombinant human eryhtropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatric Research 1993;34:675-9.
  • Soubasi 1995 {published data only}
  • Soubasi V, Kremenopoulos G, Diamanti E, Tsantali C, Sarafidis K, Tsakiris D. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. Journal of Pediatrics 1995;127:291-7.
  • Soubasi 2000 {published data only}
  • Soubasi V, Kremenopoulos G, Tsantali C, Savopoulou P, Mussafiris C, Dimitrou M. Use of erythropoietin and its effects on blood lactate and 2,3-diphosphoglycerate in premature neonates. Biology of the Neonate 2000;78:281-7.
  • Yeo 2001 {published data only}
  • Yeo CL, Choo S, Ho LY. Effect of recombinant human erythropoietin on transfusion needs in preterm infants. Journal of Paediatrics and Child Health 2001;37:352-8.
  • References to studies excluded from this review
  • Amin 2002 {published data only}
  • Amin AA, Alzahrani DM. Efficacy of erythropoietin in premature infants. Saudi Medical Journal 2002;23:287-90.
  • Brown 1999 {published data only}
  • Brown MS, Keith III JF. Comparison between two and five doses a week of recombinant erythropoietin for anemia of prematurity: a randomized trial. Pediatrics 1999;104:210-15.
  • Fearing 2002 {published data only}
  • Fearing MK, Eades B, Martinez B, Wood N, Accardo L, Browning CA, Gill WL. Cost effective use of recombinant erythropoietin (HuEPO) in very low birth weight (VLBW) infants for improved clinical outcomes. Pediatric Research 2002;51:310A.
  • Haiden 2006a {published data only}
  • Haiden N, Schwindt J, Cardona F, Berger A, Klebermass K, Wald M, et al.Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics 2006;118:2004-13.
  • Haiden 2006b {published data only}
  • Haiden N, Klebermass K, Cardona F, Schwindt J, Berger A, Kohlhauser-Vollmuth C, et al.A randomized, controlled trial of the effects of adding vitamin B12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics 2006;118:180-8.
  • Juul 2008 {published data only}
  • Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE. A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008;122:383-91.
  • Krallis 1999 {published data only}
  • Krallis N, Cholevas V, Mavridis A, Georgiou I, Bourantas K, Andronikou S. Effect of recombinant human erythropoietin in preterm infants. European Journal of Haematology 1999;63:71-6.
  • Maier 1998 {published data only}
  • Maier RF, Obladen M, Kattner E, Natzschka J, Messer J, Regazzoni BM, et al.High- versus low-dose erythropoietin in extremenly low birth weight infants. Journal of Pediatrics 1998;132:866-70.
  • Ohls 1996 {published data only}
  • Ohls RK, Veerman MW, Christensen RD. Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. Journal of Pediatrics 1996;128:518-23.
  • Turker 2005 {published data only}
  • Turker G, Sarper N, Gokalp S, Usluer H. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants. American Journal of Perinatology 2005;22:449-55.
  • Zhu 2009 {published data only}
  • Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L, et al.Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009;124:e218-26.
  • Additional references
  • Aher 2006a
  • Aher SM, Ohlsson A. Late administration of erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004868.pub2]
  • Aher 2006b
  • Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004865.pub2]
  • Begg 1996
  • Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al.Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
  • Brown 1983
  • Brown MS, Phibbs RH, Garcia JF, Dallman PR. Postnatal changes in erythropoietin levels in untransfused premature infants. Journal of Pediatrics 1983;103:612-7.
  • Brown 1990
  • Brown MS, Berman ER, Luckey D. Prediction of the need for transfusion during anemia of prematurity. Journal of Pediatrics 1990;116:773-8.
  • Cohen 1998
  • Cohen A, Manno C. Transfusion practices in infants receiving assisted ventilation. Clinics in Perinatology 1998;25:97-111.
  • Dallman 1981
  • Dallman PR. Anemia of prematurity. Annual Review of Medicine 1981;32:143-60.
  • Dame 2001
  • Dame C, Juul SE, Christensen RD. The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biology of the Neonate 2001;79:228-35.
  • Finch 1982
  • Finch CA. Erythropoiesis, erythropoietin and iron. Blood 1982;60:1241-6.
  • Garcia 2002
  • Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on "late" transfusions in the neonatal intensive care unit: a meta-analysis. Journal of Perinatology 2002;22:108-11.
  • Genen 2004
  • Genen LH, Klenoff H. Iron supplementation for erythropoietin-treated preterm infants (Protocol). Cochrane Database of Systematic Reviews 2001, Issue 1. [DOI: 10.1002/14651858.CD003061.pub2]
  • Hesse 1997
  • Hesse L, Eberl W, Schlaud M, Poets CF. Blood transfusion. Iron load and retinopathy of prematurity. European Journal of Pediatrics 1997;156:465-70.
  • Juul 1999
  • Juul SE. Erythropoietin in the neonate. Current Problems in Pediatrics 1999;29:129-49.
  • Juul 2002
  • Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatrica Supplement 2002;91:36-42.
  • Klaus 1986
  • Klaus MH, Fanaroff AA. Care of the high-risk neonate (Third edition). Philadelphia, London, Toronto: W.B. Saunders Campany, 1986.
  • Klaus 1987
  • Klaus M, Fanaroff A. Asistencia del recien nacido de alto riesgo, 3e edicion. Panamericana, 1987.
  • Kotto-Kome 2004
  • Kotto-Kome AC, Garcia MG, Calhoun DA, Christensen RD. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on "early" and "late" erythrocyte transfusions: a meta-analysis. Journal of Perinatology 2004;24:24-9.
  • Lee 1995
  • Lee DA, Slagle TA, Jackson TM, Evans CS. Reducing blood donor exposures in low birth weight infants by the use of older, unwashed packed red blood cells. Journal of Pediatrics 1995;126:280-6.
  • Liu 2006
  • Liu A, Fayard E, Dunbar J, Chan A, Niemeyer M. High-dose recombinant human erythropoietin may increase the incidence and severity of ROP in premature infants. Pediatric Academic Societies' 2006 Annual Meeting. http://www.abstracts2view.com/pas/. 2006.
  • Maier 2000
  • Maier RF, Sonntag J, Walka MM, Liu G, Metze B, Obladen M. Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. Journal of Pediatrics 2000;136:220-4.
  • Manzoni 2005
  • Manzoni P, Maestri A, Gomirato G, Takagi H, Watanabe D, Matsui S. Erythropoietin as a retinal angiogenic factor. New England Journal of Medicine 2005;353:2190-1.
  • Morita 2003
  • Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki ST, Nakajima O, et al.HLF/HIF-2 alpha is a key factor in retinopathy of prematurity in association with erythropoietin. The EMBO Journal 2003;22:1134-46.
  • Musante 2006
  • Musante G, Gederlini A, Prudent L, the Neocosur Collaborative Network. Treatment with erythropoietin and incidence of retinopathy of prematurity in ELBW infants. Pediatric Academic Societies' 2006 Annual Meeting. http://www.abstracts2view.com/pas/. 2006.
  • Ohls 2000
  • Ohls RK. The use of erythropoietin in neonates. Clinics in Perinatology 2000;27:681-96.
  • Ohls 2002
  • Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. Journal of Pediatrics 2002;141:3-6.
  • Rudzinska 2002
  • Rudzinska IM, Kornacka MK, Pawluch R. Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity [Leczenie preparatami ludzkiej rekombinowanje erytropoetyny a czestosc retionpatii u noworodkow przedwczesnie urodzonych]. Przeglad Lekarski 2002;59 Supplement 1:83-5.
  • Shah 2005
  • Shah NC, Kim R, Jadav P, Cohen LM, Jean Baptiste D, Weedon J. Effect of recombinant human erythropoietin (rhEPO) on the development of retinopathy of prematurity (ROP). Pediatric Research 2005;57:546A (abstract).
  • Shannon 1995
  • Shannon KM, Keith JF 3rd, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA, et al.Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 1995;95:1-8.
  • Stockman 1978
  • Stockman JA 3rd, Oski FA. Physiological anaemia of infancy and the anaemia of prematurity. Clinics in Hematology 1978;7:3-18.
  • Stockman 1986
  • Stockman JA 3rd. Anemia of prematurity. Current concept in the issue of when to transfuse. Pediatric Clinics of North America 1986;33:111-28.
  • Strauss 1986
  • Strauss RG. Current issues in neonatal transfusions. Vox Sanguinis 1986;51:1-9.
  • Vamvakas 2001
  • Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion 2001;41:406-15.
  • Watanabe 2005
  • Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M, et al.Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. New England Journal of Medicine 2005;353:782-92.
  • Widness 1996
  • Widness JA, Seward VJ, Kromer IJ, Burmeiser LF, Bell EF. Changing patterns of red blood cell transfusion in very low birth weight infants. Journal of Pediatrics 1996;129:680-7.
  • Zipursky 2000
  • Zipursky A. Erythropoietin therapy for premature infants: cost without benefit?. Pediatric Research 2000;48:136.
  • References to other published versions of this review
  • Ohlsson 2006
  • Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004863.pub2]